Search

Desiree H Tsao

from Belmont, MA
Age ~61

Desiree Tsao Phones & Addresses

  • 60 Scott Rd, Belmont, MA 02478 (617) 489-3808
  • San Francisco, CA
  • 137 Freeman St, Brookline, MA 02146 (617) 734-3870
  • Tucson, AZ
  • Bethesda, MD
  • Davis, CA
  • 60 Scott Rd, Belmont, MA 02478 (857) 205-0207

Work

Position: Production Occupations

Education

Degree: High school graduate or higher

Emails

Industries

Pharmaceuticals

Resumes

Resumes

Desiree Tsao Photo 1

Principal Scientist, Phd At Wyeth Research

View page
Location:
Greater Boston Area
Industry:
Pharmaceuticals

Publications

Us Patents

N-Tradd Active Site And Uses Thereof

View page
US Patent:
20050002898, Jan 6, 2005
Filed:
Jul 20, 2004
Appl. No.:
10/894834
Inventors:
Desiree Tsao - Belmont MA, US
Jean-Baptiste Telliez - Waltham MA, US
Thomas McDonagh - Acton MA, US
Lih-Ling Lin - Concord MA, US
Sang Hsu - Lexington MA, US
A. Malakian - Boxborough MA, US
International Classification:
A61K038/19
C07K014/52
US Classification:
424085100, 530351000
Abstract:
The present invention relates to the three dimensional solution structure of the N-terminal domain of TNFR-1 associated death domain protein (“N-TRADD”), as well as the identification and characterization of a C-TRAF2 binding active site of N-TRADD. Also provided for by the present invention are methods of utilizing the three dimensional structures for the design and selection of potent and selective inhibitors of TNF signaling pathways.

N-Tradd Active Site And Uses Thereof

View page
US Patent:
20020094540, Jul 18, 2002
Filed:
Mar 29, 2001
Appl. No.:
09/821819
Inventors:
Desiree Tsao - Belmont MA, US
Jean-Baptiste Telliez - Waltham MA, US
Thomas McDonagh - Acton MA, US
Lih-Ling Lin - Concord MA, US
Sang Hsu - Lexington MA, US
A. Malakian - Boxborough MA, US
International Classification:
G01N033/53
G06F019/00
G01N033/48
G01N033/50
C12N009/64
US Classification:
435/007100, 702/019000, 435/226000
Abstract:
The present invention relates to the three dimensional solution structure of the N-terminal domain of TNFR-1 associated death domain protein (“N-TRADD”), as well as the identification and characterization of a C-TRAF2 binding active site of N-TRADD. Also provided for by the present invention are methods of utilizing the three dimensional structures for the design and selection of potent and selective inhibitors of TNF signaling pathways.
Desiree H Tsao from Belmont, MA, age ~61 Get Report